Design Therapeutics, Inc. (DSGN)
NGS · Common · CUSIP 25056L103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for DSGN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
25056L103
Market Cap
Mid Cap
IPO
3/26/2021 · $20.00/share
Business: Design Therapeutics, Inc. is a biopharmaceutical company pioneering novel small-molecule therapeutic candidates that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.

Company Contact

CEO
João Siffert
CFO
João Siffert
Headquarters
6005 Hidden Valley Road, Suite 110, Carlsbad, CA 92011
Phone
858-293-4900
Investor Relations
Alicia Davis, THRUST Strategic Communications · 910-620-3302 · renee@thrustsc.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »